XTRA Bitcoin Inc (CBTC)

[surfkast]

On August 26, 2011, Therapy Cells Inc purchased 90.9% of the Common Stock of Therapy Cells Limited(TCL), a New Zealand Corporation, for 3,000,000 shares of it’s Preferred Series C Stock. TCL is actively doing business in the cell repair and cell replacement of Equine stock at present but actively pursuing FDA approval to be used for repair of the Human Body. Since the company’s acquisition of TCL they have made a decision to pursue only Therapy Cell related business in the future.